Canadian Compassionate Company Designation
On August 29, 2017, Canadian Hospice Palliative Care Association (CHPCA)’s Champion’s Council announced Innovative Medicines Canada has been designated a Canadian Compassionate Company (CCC). A commitment to supporting employees through caring for seriously ill and injured loved ones has led to achieving this designation.
Pamela Fralick, President of Innovative Medicines Canada, expressed her pleasure upon receiving news of this designation:
“This designation builds on Innovative Medicines Canada’s long and proud tradition as a progressive and compassionate employer. Our employees have made this association the success it is today, and our CCC designation reflects our policy of supporting our people through all of life’s challenges.”
Read the full release (on the CHPCA website).